Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLCN2 | P51788 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.41 |
| ▸ | F2R | P25116 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8114342 | 0.84 | CLCN2 (0.42) | CLCN2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL10308375 | 0.84 | PDK2 (0.46) | ALDH1A1TSHRMEN1KMT2APDK2 | |
| SCHEMBL17058837 | 0.83 | ALDH1A1 (0.41) | ALDH1A1TSHRMEN1KMT2APDK2 | |
| SCHEMBL3364147 | 0.83 | CLCN2 (0.41) | CLCN2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL29532527 | 0.83 | CLCN2 (0.41) | CLCN2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL11397191 | 0.83 | TSHR (0.43) | ALDH1A1TSHRMEN1KMT2ATP53 | |
| SCHEMBL17058912 | 0.82 | BCAT2 (0.54) | ALDH1A1 | |
| Lithium Ion SCHEMBL8120160 | 0.81 | CLCN2 (0.37) | CLCN2GABRA1GABRB2ALDH1A1TSHR | |
| Potassium Ion SCHEMBL8104534 | 0.81 | CLCN2 (0.37) | CLCN2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL24260294 | 0.80 | HPGD (0.41) | ALDH1A1TSHRMEN1KMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150246958-A1 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | BAIKANG (SUZHOU) CO., LTD (CN) | 2015-09-03 | — | — | US | disclosed |
| US-8507727-B2 | Method for producing cyclohexyl alkyl ketones | MITSUBISHI GAS CHEMCIAL COMPANY, INC. (JP) | 2013-08-13 | — | — | US | disclosed |
| EP-2479163-A1 | METHOD FOR PRODUCING CYCLOHEXYL ALKYL KETONES | Mitsubishi Gas Chemical Company, Inc. (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120178970-A1 | METHOD FOR PRODUCING CYCLOHEXYL ALKYL KETONES | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2012-07-12 | — | — | US | disclosed |
| US-7906655-B2 | 5,5'-(1,2-ethynediyl)bis(2-((2S)-1-((2R)-2-phenylpropanoyl)-2-pyrrolidinyl)-1H-benzimidazole); inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-03-15 | — | — | US | disclosed |
| US-20100068176-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100068176-A1 | HEPATITIS C VIRUS INHIBITORS | HAVCR2, PYGL, HCCS | CLCN2 3980/4885GABRA1 3946/4885GABRB2 2831/4885 |
| US-20150246958-A1 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | NOS2, EGLN2, HPGD | CLCN2 3712/4885GABRA1 2991/4885GABRB2 1984/4885 |
| US-20120178970-A1 | METHOD FOR PRODUCING CYCLOHEXYL ALKYL KETONES | HACL2, ALKBH3, HSD17B7 | CLCN2 404/4885GABRA1 3183/4885GABRB2 3463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.